Summary: Utilizing an advanced, home-grown PET radiotracer, the team mapped tau deposits in 37 PSP patients and combined this structural data with functional connectivity coordinates from 100 healthy control brains. The empirical data unmasked a shared, remote network architecture dubbed the “PSP-tau network.”
The study confirms that deep, local tau clusters impair high-level cognition by sending disruptive, echo-like signals along healthy neural pathways to disable distant, clear areas of the cerebral cortex.
Key Facts
- The Remote Network Hypothesis Validated: The study demonstrates that the clinical symptoms of neurodegenerative disease are not solely dictated by where a toxic protein aggregates locally. Instead, localized protein buildup can travel through, or electronically disrupt, distant cortical regions along established neural highways.
- The “PSP-Tau Network” Discovered: While the precise, local footprint of tau buildup varied from patient to patient, connectomic tracking unmasked that all affected subcortical zones were functionally hardwired to a shared set of distant cortical structures. This common, vulnerable circuit comprises the prefrontal cortex, anterior cingulate cortex, anterior insula, and parietal cortex—the precise control hubs that govern executive function, attention, working memory, and behavioral inhibition.
- The Mechanistic Decoupling of Symptoms: The QST data revealed a clear division in how symptoms develop:
- Motor Deficits (Local): The raw volume of tau pooled locally within deep subcortical movement centers (like the midbrain, caudate, and putamen) accurately predicted eye movement paralysis and physical stiffness, but showed no link to mental decline.
- Cognitive Deficits (Remote): The statistical strength of the connection between those deep tau deposits and the distant PSP-tau network directly predicted the severity of a patient’s frontal cognitive impairment.
- Solving Clinical Heterogeneity: This circuit-based model elegantly explains a long-standing mystery in neurology: why patients with highly diverse or asymmetrical patterns of visible brain pathology often manifest identical clinical symptoms. They develop identical deficits because their unique localized lesions happen to intercept the same shared network.
- Extending to Alzheimer’s and Frontotemporal Dementias: Dr. Toshiyuki Hirabayashi notes that this structural shift carries massive, sweeping implications for broader dementia research. Because tau accumulation is a core feature of Alzheimer’s disease and frontotemporal lobar degeneration, deploying functional connectome mapping will allow scientists to map symptom-specific circuits across multiple distinct neurodegenerative conditions.
- A New Horizon for Precision Therapeutics: Shifting neuroscience away from evaluating “isolated spots of damage” paves the way for advanced network-based precision medicine. Future clinical interventions can focus on protecting circuit integrity, predicting precise symptom timelines before they physically manifest, and tailoring personalized neuromodulation therapies.
Source: QST
Researchers at Japan’s National Institutes for Quantum Science and Technology (QST) have found that tau buildup in progressive supranuclear palsy (PSP) may affect brain networks involved in thinking and behaviour. The findings suggest that symptoms may arise not only from where tau builds up in the brain, but also from how those affected areas are connected to distant brain regions.
The study was published online on July 10, 2026, in Science Advances.
PSP is a rare neurodegenerative disease caused by the abnormal accumulation of tau, a protein associated with several forms of dementia. The disease often leads to falls, problems with eye movement, stiffness, and cognitive or behavioral symptoms such as reduced attention and difficulty controlling emotions.
A long-standing question in PSP is why patients develop cognitive symptoms even when tau is concentrated mainly in deep brain regions involved in movement. Many of the symptoms appear to involve the cerebral cortex, the outer layer of the brain that supports attention, decision-making, and flexible behavior, even when those cortical areas show little direct tau buildup.
To investigate this mismatch, the QST team combined tau positron emission tomography (tau PET) with brain network mapping. Using a tau PET tracer developed by QST, the researchers visualized tau deposits in 37 patients with PSP. They then combined each patient’s tau-affected areas with brain connectivity data from 100 healthy individuals to identify distant regions that were functionally connected to the sites of pathology.
Although the precise locations of tau buildup differed from patient to patient, the affected regions were commonly connected to a shared set of cortical areas. These included the prefrontal cortex, anterior cingulate cortex, anterior insula, and parietal cortex—regions involved in executive functions such as attention, planning, inhibition, and behavioral control. The researchers call this shared circuit the “PSP-tau network.”
The strength of the connection between each patient’s tau deposits and this PSP-tau network was associated with the severity of frontal cognitive impairment. In contrast, the amount of tau in deep brain regions was associated with motor symptoms, such as eye movement problems, but not with the same cognitive symptoms. The findings suggest that movement and cognitive symptoms in PSP may arise through different mechanisms: local tau-related damage in motor-related regions and remote disruption of a broader cognitive network.
“Our study began with a clinical question that could not be answered by looking only at where tau accumulates,” said Dr. Toshiyuki Hirabayashi, Senior Principal Researcher at the Advanced Neuroimaging Center, QST. “We wanted to know whether local tau pathology could affect distant brain regions through neural circuits and whether that remote effect could explain the symptoms patients experience.”
The results provide evidence that tau pathology in PSP can be linked to cognitive symptoms through a common remote brain network, even when the visible pattern of tau accumulation varies among patients. This circuit-based view may help explain why people with different patterns of brain pathology can develop similar symptoms.
The findings may also have implications beyond PSP. Tau buildup is a key feature of several neurodegenerative diseases, including Alzheimer’s disease. If disease-related proteins can impair cognition by disrupting connected brain circuits, similar approaches could help identify symptom-related networks in other disorders and support more accurate prediction of disease-related changes.
“These results suggest that we should not view neurodegenerative disease only as damage at isolated spots in the brain,” Dr. Hirabayashi said. “By identifying the circuits that connect pathology to symptoms, we hope to contribute to treatments that are better matched to each patient’s condition.”
In the longer term, this network-based view could help researchers better understand how tau-related diseases affect the brain and may support future efforts toward earlier diagnosis, more accurate symptom prediction, and more personalized treatment strategies.
Funding information
This work was supported by AMED under Grant Numbers JP25wm0625307 and JP25wm0625001, JST under Grant Number JPMJMS2024, and JSPS KAKENHI under Grant Numbers JP24H00734, JP25H01767, and JP23K11796.
Key Questions Answered:
A: For over a century, neurology has operated on a basic “local damage equals local deficit” rule, if a patient loses the ability to speak, you look for a lesion in the speech center of the brain. In PSP, patients experience profound mental struggles, losing their ability to plan, focus, and manage emotions. According to the old rule, these high-level executive issues should mean the outer cerebral cortex (the frontal lobe) is heavily damaged and choked with toxic tau proteins. Yet, when doctors looked at standard scans, the cortex appeared relatively clean, while the tau protein was tightly bunched up in deep, primitive areas responsible for movement. This mismatch left science completely unable to explain why a movement-centered brain lesion could scramble a patient’s personality and thoughts.
A: It acts like a localized traffic jam on a major highway that ends up stalling traffic in a city miles away. The brain is not a collection of isolated islands; it is a hyper-connected, electrical grid. The deep subcortical structures affected by PSP (like the midbrain and caudate) serve as vital relay stations that continuously talk to the outer prefrontal cortex via dense neural circuits. When tau builds up and damages these deep relay stations, it alters the electrical rhythm. Even though the distant prefrontal cortex remains physically free of tau, it stops receiving the clean data streams it needs to operate, causing its high-level executive systems to stall out remotely due to circuit starvation.
A: This study shifts the entire philosophy of neurodegeneration from a static “dead spot” model to a dynamic “network circuit” model. Historically, drug companies designed treatments aimed solely at clearing out a visible clump of protein in one specific spot, which often failed to improve a patient’s daily cognitive life. By mapping the exact “PSP-tau network,” Japan’s QST has provided a clear blueprint of the functional lines that must be protected. This allows medical science to catch and predict cognitive decline years before the tissue physically deteriorates, opening the door for precision therapies like targeted deep brain stimulation or transcranial magnetic stimulation to electrically reinforce the circuit and keep the human mind functional.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this PSP and cognition research news
Author: Rin Suzuki
Source: QST
Contact: Rin Suzuki – QST
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Remote network for cognitive symptoms derived from tau accumulation in progressive supranuclear palsy” by Chie Seki, Hironobu Endo, Hitoshi Shimada, Hitoshi Shinotoh, Keisuke Takahata, Kenji Tagai, Makoto Higuchi, Naomi Kokubo, Ryoji Goto, Shin Kurose, Sho Moriguchi, Takafumi Minamimoto, Takahiko Tokuda, Toshiyuki Hirabayashi, Yuki Hori, Yuki Momota, Yuko Kataoka. Science Advances
DOI:10.1126/sciadv.aed0348
Abstract
Remote network for cognitive symptoms derived from tau accumulation in progressive supranuclear palsy
Progressive supranuclear palsy (PSP) is a neurodegenerative disorder with motor and cognitive impairments. Whereas motor symptoms are associated with subcortical tau deposits, the mechanisms underlying the cognitive symptoms remain unclear due to heterogeneous and primarily subcortical distribution of pathological tau deposits.
Here, we combined tau-PET (tau positron emission tomography) using a high-contrast probe we developed with a normative connectome in 37 patients with PSP and 48 healthy controls.
We found that tau deposition sites functionally connected to a common cortical network that could not be derived from atrophy. This network predominantly overlapped with canonical action-mode and frontoparietal networks, which support adaptive, goal-directed behavior.
Whereas the extent of primary tau deposition predicted motor symptoms, the normative connectivity strength from tau deposition sites to the identified cortical network explained the severity of cognitive deficits.
These findings suggest a previously unknown mechanism that cognitive, but not motor, deficits in PSP arise from remote effects of tau deposition—independent of atrophy—via convergent connectivity to a common cortical network.
